S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

MIST Milestone Pharmaceuticals Inc

2.0588

0.0088 (0.43%)

Jan 24 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Milestone Pharmaceuticals (NASDAQ:MIST)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Milestone Pharmaceuticals Charts.

Milestone Pharmaceuticals (NASDAQ:MIST)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Milestone Pharmaceuticals Charts.

Milestone Pharmaceuticals Inc News

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 7 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Sunday 24 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 September 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 August 2024 (5 months ago) • Edgar (US Regulatory)

More Milestone Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions